See a list of COVID-19 funding opportunities 

--

CDMRP Melanoma Research Program

Required Pre-proposals: June 22, 2020 | Full Proposal: September 24, 2020

CDMRP Peer Reviewed Cancer Research Program

Resources: 

National Institutes of Health 

  • Institutional Translational Research Training Program (T32): This program aims to equip trainees with the knowledge and skills needed to advance basic research toward clinical application. These programs are intended to be 2 years in duration and support training of one or more of the following groups: advanced predoctoral students, postdoctoral fellows and fellowship-stage clinicians. Letter of Intent due 30 days prior to due date(s). Next full application due May 27, 2020. 
  • Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional): This FOA aims to accelerate translational and clinical Phase I and II a/b safety and efficacy studies for substantiating measurable functional benefits of probiotic/prebiotic components and/or their combinations; and to understand the underlying mechanisms of their action(s), and variability in responses to these interventions. Standard due dates apply. 

COBRE Center for Addiction and Disease Risk Exacerbation (CADRE)

  • Pilot Project Award Program: The program will award two pilot projects of $50,000 each led by early-career investigators from diverse disciplinary backgrounds. The CADRE aims to increase the quantity and quality of research on mechanisms linking substance and chronic disease. Application materials are accepted on a rolling basis.
  • Research Project Leader Award Program: Four thematically- and technically-linked research projects will be led by Project Leaders who are early career investigators. Project leaders will receive funding to conduct multi-disciplinary research on mechanisms linking substance use disorders with chronic disease conditions, and receive individualized mentorship and support to ensure career enrichment and successful transition to an RO1 level-funded investigator at the end of their project. Annual support of approximately $150,000 DC per year may be requested for a project period of up to 36 months. Applications are accepted on a rolling basis. 

Brown Data Science Grants

  • Brown's Data Science Initiative offers funding opportunities for collaborative projects that support our mission, namely to: facilitate and conduct both domain-driven and fundamental research in data science; increase data fluency and educate the next generation of data scientists; explore the impact of the data revolution on culture, society, and social justice. We are particularly interested in funding new initiatives and collaborations, and will not fund the continuation of existing research projects. Brown faculty and postdoctoral fellows are eligible to apply. We plan to fund both small and larger grant proposals. Please note that we do not provide funding for faculty salaries. We anticipate having $200 – $250k available in FY19. Proposals are accepted on a rolling basisLearn more

Diabetes Research & Wellness Foundation 

  • Research applications related to finding the cause, prevention, treatment, and cure of diabetes and its complications. Applications accepted year-round. 

COBRE on Opioids and Overdose

  • Call for Pilot Project Applications: We would like to announce the availability of 3-5, one year grants for up to $40,000 for research related to the central theme of the COBRE program. This opportunity is open to applicants may include post-doctoral fellows ready to make the transition to junior faculty positions, junior faculty, as well as established faculty. Applicants are encouraged from all Rhode Island Colleges and universities, and affiliated research hospitals, institutions and centers. Applications will be due at 5 p.m. on the first of any month. Requests for pilot project funding are evaluated on a rolling basis. 

Online Partnership to Accelerate Research: 

  • Leidos Health has partnered with NIH to accelerate the biomedical research and development enterprise by matching high-scoring (e.g., those within the 30th percentile), unfunded NIH applications with private biomedical foundations and/or industries seeking to fund promising research via OnPAR. Learn more.